The University of Western Virginia and GATC Health Partner to launch a strategic program for accelerating academic research on market therapies – Yahoo Finance
The innovative program uses the GATC AI platform for rapid de-risk and optimization of drug detection and development, accelerating the transition to clinical trials.
Morgantown, W.VA.., January 28, 2025 / Prnewswire/ – West Virginia University (S)Wvu), one of the best public research institutions in the country, has created a strategic partnership with the GATC Health Corp, a leading technology company using artificial intelligence (AI) to transform drug detection. Cooperation agreement facilitates the combination of Wvu’s An early -stage drug study and GATC drug detection platform to accelerate commercialization and create skimmed investment opportunities in biotechnology.
The patented GATC Health AI helps detect diseases early and creates more festive, more effective drugs by mimicing the complex interactions of human biology. (Prnewsfoto/gatc Health)
The program aims to distort and accelerate the commercialization of innovative research conducted on WvuS Using Multiomics Advanced Technology ™ (MAT) of GATC Health, which simulates complex biology of systems with approximately 90% accuracy, the program enables researchers to simulate billions -the early stages of drug development. By predicting the effects of safety, efficacy and extraordinary, the GATC platform reduces the risk, time and cost of traditional drug detection, while simulating the results of clinical trials before the start of laboratory work. GATC technology has contributed to significant discoveries in the dependence, PTSR, diabetes, obesity, glioblastoma and cognitive decline.
The partnership not only progresses academic research, but also creates insurmountable investment opportunities, significantly reducing the risks traditionally related to biopharma endeavors. By using the GATC Health AI, the program identifies projects with high potential at the beginning of the drug development process. This precision allows for faster decision making while defining university studies, as it progresses to preclinical work, establishing studies and clinical trials. As an exceptional AI partner with Lloyd’s of London Syndicate Medical & Commercial International and in partnership with Acrisure RE Corporate Consulting and Solutions, the International Financing and Consultation Company responsible for the sales and distribution of the program, GATC supports the signing of the first financial program supported by CLINING Insurance safe place and an innovative source of funding for joint ventures arising from Wvu and GATC cooperation.
“This partnership emphasizes The University West Virginia Dedication to the stimulation of innovation and transforming life through innovative research, “said Dr. MarchChancellor and Executive Dean for Health Sciences of University Western VirginiaS “By joining forces with GATC Health and using their avant -garde AI technology, we allow our researchers to accelerate the path from academic discoveries to life -changing therapies, ensuring that they guarantee life -changing therapies by ensuring Wvu It remains at the forefront of dealing with critical challenges in healthcare and achieving meaningful results that are beneficial for patients in Western Virginia And all over the world. “
Traditional drug detection and development is the famous risky, expensive and time -consuming process that often requires more than a decade and billions of dollars to market a therapy. High degree of insufficiency – almost 90% of drug candidates fail during clinical trials – stimulates from challenges such as inaccurate identification of the target, unforeseen toxicity, poor efficacy and prolonged processes of preclinical and clinical trials. By applying AI to GATC Health during these critical stages, the detection of drugs is becoming more and more effective and more likely to succeed.
“We are glad to partner Wvu and launch our University Accelerators Program for Research, “said Tyron LamCEO of GATC Health Corp. “This cooperation emphasizes our commitment to empowering academic institutions with avant-garde AI tools that overcome the difference between research and commercialization, which allows faster delivery of life-changing therapies.”
Focusing on projects with a high probability and use of GATC GATC, AI, AI, AI, AI, Wvu It will not only improve its research capacity, but will also generate revenue much earlier in the detection process. This innovative approach establishes Wvu As a leader in commercialization, managed by AI.
Gatc West Virginia, a subsidiary of GATC Health, improves its AI laboratory operations in the WVU Innovation building strategically located near to The University West Virginia campus. The modern laboratory facilitates the rapid iteration between GATC MAT AI and traditional laboratory experiments. It is currently focused on the synthesis of medicinal compounds, a critical step in improving pre -clinical tests for innovative treatments aimed at conditions such as violation of the use of opioids, disorder of the use of Polisub, post -traumatic stress disorder, anxiety, diabetes, glioblastoma and Alzheimer and Others. To support this growth, the GATC West Virginia expands its preclinical capabilities, hiring additional scientists this year, intensifying its commitment to innovation and scientific achievements.
Around University Western Virginia University Western Virginialocated in Morgantown, WVis a leading public research institution dedicated to the creation of decisions that deal with the challenges of today and tomorrow. Through their initiatives for world -class faculties and innovative research initiatives, Wvu Manages the progress in a wide range of disciplines.
For GATC Health Corp The GATC Health Corp is a technology company that revolves the detection and development of drugs through its transformative AI platform and approach. The company’s validated and own multriotic Advanced Technology ™ simulates billions of interactions of human biochemistry to quickly create new therapeutics, identify and confirm goals, accelerate the development and decoration of drugs for drugs by predicting efficiency, safety and off -up. Visit www.gatchealth.com for more information.
By james art 
